The Jak Inhibitor Ruxolitinib Is Effective in Treating T Cell Acute Lymphoblastic Leukemia with Gain of Function Mutations in Il-7R Alpha
AuthID
P-00K-7Z5
P-00K-7Z5
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service